Edgen Stock·Dec 02 2025, 08:24Back
Aclaris Therapeutics Outlines 2026 Clinical Milestones in Q3 Financial Report
Edgen Stock·Dec 02 2025, 08:24
[1] Otsuka’s kidney therapy gets accelerated FDA approval - Longevity.Technology (https://longevity.technology/news/otsukas-kid ...)[2] Belite plans filing for oral Stargardt drug after phase 3 win - pharmaphorum (https://pharmaphorum.com/news/belite-plans-fi ...)[3] ZYUS Life Sciences Announces Grant of Stock Options and Deferred Share Units - Financial Times (https://markets.ft.com/data/announce/detail?d ...)
